Dr. Mateen Moghbel
Dr. Mateen Moghbel is a dual board-certified diagnostic radiologist and nuclear medicine physician whose work spans cancer imaging, PET imaging, radiopharmaceutical therapy, and artificial intelligence in imaging interpretation.
Role
Medical Director, United Theranostics of Los Angeles
Board Certifications
American Board of Radiology and American Board of Nuclear Medicine
Clinical Focus
Cancer imaging, PET imaging, radiopharmaceutical therapy, nuclear medicine, and AI-assisted imaging interpretation
Affiliations
Diplomate of the American Board of Radiology and the American Board of Nuclear Medicine
Overview
Dr. Mateen Moghbel, MD, is a diagnostic radiologist and nuclear medicine physician specializing in cancer imaging and radiopharmaceutical therapy. His research has contributed to peer-reviewed work in PET imaging, molecular imaging, and the use of artificial intelligence in imaging interpretation.
With training at Stanford and Harvard-affiliated Massachusetts General Hospital, Dr. Moghbel combines academic depth with a patient-centered approach to personalized, evidence-based cancer care.
Locations
Education & Training
Dr. Moghbel earned his medical degree from the Stanford University School of Medicine. He completed diagnostic radiology residency training followed by fellowships in nuclear medicine and musculoskeletal imaging at Massachusetts General Hospital, a major teaching hospital of Harvard Medical School.
He holds dual board certification from the American Board of Radiology and the American Board of Nuclear Medicine.
Clinical Focus
Dr. Moghbel’s clinical focus includes diagnostic radiology, nuclear medicine, cancer imaging, PET imaging, molecular imaging, and radiopharmaceutical therapy.
At United Theranostics of Los Angeles, he leads care designed to connect advanced imaging with precision radiopharmaceutical treatment planning.
Leadership & Appointments
As Medical Director of United Theranostics of Los Angeles, Dr. Moghbel leads a team focused on delivering advanced precision medicine through molecular imaging and radiopharmaceutical therapy.
He also oversees research initiatives that seek to expand access to innovation in cancer diagnosis and management. Prior to joining United Theranostics, he practiced as a radiologist at Massachusetts General Hospital.
Research & Publications
Dr. Moghbel’s academic interests include molecular imaging, radiopharmaceutical therapies, PET imaging, cancer imaging, and the integration of artificial intelligence into imaging interpretation.
His research has been published in leading medical journals and cited more than 1,000 times, reflecting contributions to diagnostic radiology and nuclear medicine.
Selected publications include work on artificial intelligence in chest X-ray interpretation, 18F-NaF and 18F-FDG as molecular probes in atherosclerosis, standardized response assessment criteria in lymphoma, and amyloid positron emission tomography imaging probes.
Professional Affiliations
Dr. Moghbel is board certified by the American Board of Radiology and the American Board of Nuclear Medicine. His professional work bridges diagnostic radiology, nuclear medicine, molecular imaging, and radiopharmaceutical therapy.
His clinical and research background reflects collaboration across academic medicine, cancer imaging, and multidisciplinary precision oncology.
Honors & Recognition
Dr. Moghbel’s research has been cited more than 1,000 times and has contributed to the fields of diagnostic radiology, nuclear medicine, PET imaging, and artificial intelligence in imaging interpretation.
His dual board certification and training at leading academic medical centers support his role in advancing precision cancer imaging and radiopharmaceutical care.
Contact
Dr. Moghbel practices through United Theranostics of Los Angeles.
Connect With United Theranostics
For patient, provider, or clinical trial questions, contact United Theranostics directly.